Vineis Paolo, Anttila Sisko, Benhamou Simone, Spinola Monica, Hirvonen Ari, Kiyohara Chikako, Garte Seymour J, Puntoni Riccardo, Rannug Agneta, Strange Richard C, Taioli Emanuela
Epidemiology Department, Univerisitá degli Studi di Torino, 10126 Torino, Italy.
Carcinogenesis. 2007 Sep;28(9):1902-5. doi: 10.1093/carcin/bgm039. Epub 2007 Feb 16.
To test the hypothesis of interaction among genetic variants in increasing the individual risk of cancer, we have studied the cumulative effect on lung cancer risk of variants in three metabolic genes, CYP1A1, GSTM1 and GSTT1, which are involved in the metabolism of the tobacco smoke constituents and environmental contaminants, polycyclic aromatic hydrocarbons and of other lung carcinogens. We have selected from the Genetic Susceptibility to Environmental Carcinogens pooled analysis all the studies on lung cancer conducted after 1991 in which all variants were available. The data set includes 611 cases and 870 controls. We found a cumulative effect of the combination of the a priori 'at-risk' alleles for these genes (P for trend 0.004). The risk of lung cancer was increased with the combination of CYP1A12B or CYP1A14 alleles and the double deletion of both GSTM1 and GSTT1 up to an odds ratio (OR) of 8.25 (95% confidence interval 2.29-29.77) for the combination including CYP1A1*4; among never smokers, the latter combination was associated with an OR of 16.19 (1.90-137). Estimates did not change after adjustment by the number of cigarettes smoked and duration of smoking were consistent across ethnicities and were approximately the same for adenocarcinomas and squamous cell carcinomas. These observations from a large pooled analysis strongly suggest the existence of gene-gene interactions in lung carcinogenesis. People with rare combinations of common gene variants have a high risk of cancer and can be assimilated to subjects with highly penetrant mutations.
为了检验基因变异之间的相互作用会增加个体患癌风险这一假设,我们研究了三种代谢基因CYP1A1、GSTM1和GSTT1中的变异对肺癌风险的累积影响,这些基因参与烟草烟雾成分和环境污染物、多环芳烃及其他肺癌致癌物的代谢。我们从环境致癌物遗传易感性汇总分析中选取了1991年以后进行的所有关于肺癌的研究,这些研究中所有变异均可得。数据集包括611例病例和870例对照。我们发现这些基因的先验“风险”等位基因组合具有累积效应(趋势P值为0.004)。CYP1A12B或CYP1A14等位基因与GSTM1和GSTT1双缺失的组合会增加肺癌风险,对于包含CYP1A1*4的组合,优势比(OR)高达8.25(95%置信区间2.29 - 29.77);在从不吸烟者中,后一种组合的OR为16.19(1.90 - 137)。在根据吸烟量和吸烟持续时间进行调整后,估计值没有变化,在不同种族中一致,腺癌和鳞状细胞癌的情况大致相同。来自大型汇总分析的这些观察结果强烈表明肺癌发生过程中存在基因 - 基因相互作用。具有常见基因变异罕见组合的人患癌风险高,可被视为具有高外显率突变的个体。